Table 1.
Clinical features of the 2 patients with hepatic EAML
| Case | Patient 1 | Patient 2 |
|---|---|---|
| Age (year) | 37 | 51 |
| Gender | F | F |
| Lesion Location | left lateral lobe | left lobe |
| Lesion amount | 1 | 1 |
| Size (cm) | 4.5×4.2×4.9 | 4×3.5×3.7 |
| Viral hepatitis | N | N |
| ALT (u/l) | 8 | 39 |
| AST (u/l) | 15 | 26 |
| γ-GT (u/l) | 9 | 32 |
| ALP (u/l) | 71 | 64 |
| TBIL (μmol/l) | 5.2 | 4.8 |
| IBIL (μmol/l) | 1.9 | 1.7 |
| AFP (ng/ml) | 3.29 | 2.75 |
| CEA (ng/ml) | 1.01 | 0.76 |
| CA19-9 (U/ml) | 11.31 | 4.83 |
| CA125 (U/ml) | 15.25 | 7.72 |
F, female; N, no; ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GT, γ-glutamyl transpeptidase; ALP, alkaline phosphatase; TBIL, total bilirubin; IBIL, indirect bilirubin; AFP, alpha fetoprotein; CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; CA125, carbohydrate antigen 125.